Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment

LONDON--()-- 

FORM 8.3 - Amendment to purchase and sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 20 May 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

1,817,011

1.41%

180,747

0.14%

 

(2)

Derivatives (other than options):

72,359

0.06%

94,581

0.07%

 

(3)

Options and agreements to
purchase/sell:

6,100

0.00%

6,100

0.00%

 
TOTAL:

1,895,470

1.46%

281,428

0.22%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

1

262.6500 USD

Purchase

1

264.0000 USD

Purchase

1

264.9300 USD

Purchase

2

264.9950 USD

Purchase

3

264.7733 USD

Purchase

7

264.7907 USD

Purchase

11

265.4700 USD

Purchase

26

262.8100 USD

Purchase

39

262.0000 USD

Purchase

55

264.4200 USD

Purchase

100

264.1700 USD

Purchase

100

264.0814 USD

Purchase

100

264.7600 USD

Purchase

100

264.8900 USD

Purchase

100

264.4000 USD

Purchase

109

265.2239 USD

Purchase

123

264.4235 USD

Purchase

191

264.9781 USD

Purchase

200

264.4175 USD

Purchase

246

265.2252 USD

Purchase

276

262.9989 USD

Purchase

296

264.6387 USD

Purchase

300

264.6983 USD

Purchase

300

264.1900 USD

Purchase

307

263.3651 USD

Purchase

330

263.9906 USD

Purchase

400

264.3845 USD

Purchase

401

264.2503 USD

Purchase

542

264.4480 USD

Purchase

710

264.1971 USD

Purchase

795

264.7942 USD

Purchase

912

264.2480 USD

Purchase

927

264.4720 USD

Purchase

1,659

263.7972 USD

Purchase

2,273

263.7625 USD

Purchase

2,727

264.6846 USD

Purchase

2,913

265.1180 USD

Purchase

3,006

264.8816 USD

Purchase

3,259

264.4533 USD

Purchase

5,511

265.7481 USD

Purchase

7,098

263.7955 USD

Purchase

10,000

266.0000 USD

Purchase

10,200

265.9120 USD

Purchase

17,702

264.4433 USD

Purchase

19,143

265.2054 USD

Purchase

30,000

265.4434 USD

Purchase

38,475

264.0506 USD

Purchase

87,400

264.7061 USD

Purchase

110,448

264.2600 USD

Sale

1

265.6800 USD

Sale

18

264.7406 USD

Sale

26

262.8100 USD

Sale

34

264.1600 USD

Sale

85

265.8500 USD

Sale

91

264.1400 USD

Sale

110

265.9290 USD

Sale

132

265.8971 USD

Sale

154

262.0000 USD

Sale

156

265.4012 USD

Sale

300

265.9166 USD

Sale

300

264.1900 USD

Sale

300

265.9200 USD

Sale

320

265.1078 USD

Sale

445

265.7000 USD

Sale

465

265.8892 USD

Sale

522

265.2941 USD

Sale

571

265.8998 USD

Sale

710

264.1971 USD

Sale

890

265.2026 USD

Sale

2,170

264.4167 USD

Sale

2,462

264.1708 USD

Sale

2,500

264.3196 USD

Sale

2,607

265.1016 USD

Sale

2,914

265.1919 USD

Sale

3,527

264.6538 USD

Sale

5,776

264.2600 USD

Sale

9,570

264.6051 USD

Sale

9,725

265.9422 USD

Sale

10,000

265.8529 USD

Sale

16,052

264.4799 USD

Sale

20,000

265.2388 USD

Sale

22,500

265.2272 USD

Sale

26,410

265.2408 USD

Sale

30,000

265.4434 USD

Sale

38,475

264.0506 USD

Sale

97,761

264.2599 USD

(b) Derivatives transactions (other than options transactions)

Product Name Nature of transaction Number of relevant securities Price per
unit

SWAP

Short

94,581

264.2600 USD

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

24 May 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 737996
Time of Receipt (offset from UTC): 20210524T141722+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC